Danaher’s Insider Stability Signals Long‑Term Confidence for Investors
Danaher’s latest insider filings reveal no new trades, underscoring steady executive confidence and a strong growth trajectory for investors.
3 minutes to read
Danaher Corp
Mitchell Rales Sells Shares as Danaher Expands Board, Signals Strategic Growth
Danaher insider sale by Mitchell Rales signals strategic confidence: board expansion, high‑growth focus, and strong drug‑pipeline positioning.
3 minutes to read